ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,358Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 393

$955K Total Retail Price of All Prescriptions

Rank: 3 out of 393

801 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 801 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 801 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,006 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,110 659 1 1
LISINOPRIL 956 589 2 2
OMEPRAZOLE 815 375 3 6
HYDROCODONE-ACETAMINOPHEN 808 369 S3 4 5
AMLODIPINE BESYLATE 736 490 5 4
LEVOTHYROXINE SODIUM 637 395 6 3
METFORMIN HCL 573 302 7 7
HYDROCHLOROTHIAZIDE 424 275 8 10
FUROSEMIDE 320 188 9 8
ZOLPIDEM TARTRATE 289 101 10 11
LOSARTAN POTASSIUM 287 213 11 12
OXYCODONE HCL-ACETAMINOPHEN 281 102 S2 12 54
POTASSIUM CHLORIDE 276 177 13 20
SPIRIVA 271 160 14 41
GLIPIZIDE 270 155 15 32
CITALOPRAM HBR 267 133 16 23
ATENOLOL 261 168 17 13
FLUTICASONE PROPIONATE 259 129 18 27
LOVASTATIN 251 165 19 14
GABAPENTIN 239 65 20 15
OXYCODONE HCL 222 61 S2 21 36
TIZANIDINE HCL 219 91 22 97
PROAIR HFA 215 82 23 68
ADVAIR DISKUS 214 122 24 53
MORPHINE SULFATE ER 190 35 S2 25 48
ATORVASTATIN CALCIUM 183 138 26 19
ENALAPRIL MALEATE 175 77 27 77
TRAZODONE HCL 166 50 28 47
METOPROLOL TARTRATE 154 115 29 9
ALENDRONATE SODIUM 152 109 30 16
TAMSULOSIN HCL 138 98 31 25
LANTUS SOLOSTAR 137 59 32 74
WARFARIN SODIUM 136 82 33 17
RANITIDINE HCL 129 33 34 29
CLOPIDOGREL 125 91 35 33
FLUOXETINE HCL 117 54 36 37
FELODIPINE ER 117 78 36 130
DOXAZOSIN MESYLATE 114 74 38 83
GEMFIBROZIL 113 43 39 62
PANTOPRAZOLE SODIUM 111 85 40 56
AMITRIPTYLINE HCL 107 19 R 41 72
OXYCODONE-ACETAMINOPHEN 106 54 S2 42 71
TRAMADOL HCL 104 59 43 30
PEN NEEDLE 99 40 44 81
POLYETHYLENE GLYCOL 3350 98 48 45 99
CARVEDILOL 94 52 46 21
METOPROLOL SUCCINATE 92 69 47 22
SERTRALINE HCL 90 44 48 28
CARISOPRODOL 88 25 R 49 45
OXYBUTYNIN CHLORIDE 87 42 50 90
ALLOPURINOL 87 42 50 26
AZITHROMYCIN 84 43 52 35
LYRICA 83 50 53 119
LANTUS 79 41 54 73
METHADONE HCL 76 14 S2 55 102
CRESTOR 76 44 55 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 43 57 111
VENTOLIN HFA 75 35 57 42
MECLIZINE HCL 74 44 59 163
CELEBREX 74 21 59 150
PROPRANOLOL HCL 74 58 59 134
VICTOZA 3-PAK 73 18 62 254
CYCLOBENZAPRINE HCL 73 0 R 62 109
BENAZEPRIL HCL 73 35 62 40
DIGOXIN 72 48 65 66
GLYBURIDE 72 40 R 65 46
CLONIDINE HCL 72 21 65 50
HYDROMORPHONE HCL 71 0 S2 68 138
COMBIVENT 69 24 69 169
FAMOTIDINE 66 43 70 70
KLOR-CON 10 64 29 71 113
KLOR-CON M20 62 38 72 137
TRIAMCINOLONE ACETONIDE 60 40 73 94
SYNTHROID 59 47 74 44
PLAVIX 59 48 74 51
ESTRADIOL 58 40 R 76 93
NEXIUM 58 18 76 84
DEXILANT 57 18 78 283
BUPROPION HCL SR 54 20 79 181
VERAPAMIL ER 53 31 80 86
ENDOCET 53 12 S2 80 211
METHYLPREDNISOLONE 52 31 82 80
TRIAMTERENE-HCTZ 52 40 82 49
PREMARIN 51 26 R 84 157
PHENYTOIN SODIUM EXTENDED 50 23 85 200
SPIRONOLACTONE 50 12 85 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.